Medtech is operating in one of the most complex and uncertain environments we’ve ever faced. Trade law, data privacy, AI governance, enforcement priorities, and agency authority are no longer peripheral concerns — they are at the center of boardroom conversations and c-suite strategies. At the same time, the pace of innovation and the disruptive power of AI are accelerating, raising new questions for every company in our sector.

That’s why The MedTech Conference, hosted by AdvaMed, comes at such a critical moment. From October 5–8 in San Diego, we will convene the largest concentration of medtech CEOs, senior executives, and global partners anywhere in the world. Our program was built in direct collaboration with industry leaders to reflect the real issues companies face today — from navigating tariffs and supply chain shifts, to aligning on privacy, AI adoption, enforcement priorities, and patient trust.

AdvaMed’s role is to bring these perspectives together in one place, ensuring that no single company confronts these challenges in isolation. Through unfiltered CEO discussions, corporate reverse pitches, international market access panels, and cross-functional sessions on AI, digital health, and patient engagement, our agenda connects the dots across business, regulation, and innovation. These conversations — and the strategies to move forward — will only happen here, with the full strength of the industry at the table.

In five days, the medtech industry comes together in San Diego. If you haven’t done so already, register now. I look forward to joining you there.

Christopher L. White, Esq.,

General Counsel & Chief Policy Officer,

AdvaMed